恒指服務公司公布最新一份季檢，阿里健康(0241)及海底撈(6862)等納入恒生指數，成分股由52增加至55隻，所有變動將於3月15日起生效。報導指，市場預計被動基金將要追入阿里健康超過14億元，另海底撈則超過9億元。阿里健康及海底撈股價受刺激早段開盤分別升逾7%及8%。兩者股價皆於2月創新高，上周五阿里健康回試50天線，今早重上10天線28.1元之上，如看好可留意輕微價外認購證20685，行使價 30.88 元， 2021年7月到期 ，實際槓桿 4.1 倍 。
有大行於2月初列出2021年以來北水首20大最吸資股分，海底撈排第12，有約5.9億美元。海底撈2月中曾見上市高位85.8元，惟股價於大市2月下旬回落時出現較明顯調整，上周五於100天線約61元之上暫喘定，投資者若認為染藍的消息或有助股價及波幅向好，可留意貼價認購證26640，行使價 69 元， 2021年10月到期 ，實際槓桿 3.2 倍。
其他滙豐輪證焦點:
里康認購證20685，行使價 30.88 元， 2021年7月到期 ，實際槓桿 4.1 倍。
平醫認購證27671，行使價 136.98 元， 2021年7月到期 ，實際槓桿 5.2 倍。
平醫牛證54259，行使價 97.38 元， 收回價 101.38 元， 2021年11月到期 ，實際槓桿 5.5 倍。
海撈認購證26640，行使價 69 元， 2021年10月到期 ，實際槓桿 3.2 倍。
九毛認購證26395，行使價 25.88 元， 2021年6月到期 ，實際槓桿 2.7 倍。
Stay abreast of the trends with the latest investment insight and market updates.
DB Power Online Limited, “HKEX Information Services Limited, its holding companies and/or any subsidiaries of such holding companies”, China Investment Information Services Limited, third party information providers endeavor to ensure the accuracy and reliability of the information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Structured products are complex products. Investors should exercise caution in relation to them. The price of the structured products may fall in value as rapidly as it may rise and investors may sustain a total or substantial loss of their investment. Prospective investors should ensure that they understand the nature and risks and seek professional advice where applicable. Please also note that CBBCs have a mandatory call feature and may therefore be subject to early termination, upon which (i) investors in category N CBBCs will lose all of their investments in the CBBCs; and (ii) the residual value of category R CBBCs may be zero. Inline warrants have been newly introduced to the market and there are no similar products currently listed on the Stock Exchange of Hong Kong Limited for comparison. Inline warrants carry exotic features, and their terms and pricing may be more complicated than standard derivative warrants. Maximum potential payoff is fixed and capped. Price movement of the inline warrants may be disproportionate or opposite to the price movement of the underlying asset. Trading structured products with United States (US) underlying index may be exposed to additional risks, including (a) risks relating to difference in trading days and hours, (b) less public information about the index and such information may not be available in Chinese, (c) political and economic risks relating to the index regions (such as the US), (d) exchange rate risks, (e) possible delay in settlement, and (f) publication of index level when component shares are not trading. Click here for "Terms of Use".
By viewing this website or using any information or functions of this website, you are deemed to acknowledge that you agree to the Privacy and Security, Terms of Use and Hyperlink Policy. Click here for "Disclaimer".
All data/charts are for reference purposes only.
